Skip to main navigation Skip to search Skip to main content

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

  • Lang Wu
  • , Wei Shi
  • , Jirong Long
  • , Xingyi Guo
  • , Kyriaki Michailidou
  • , Jonathan Beesley
  • , Manjeet K. Bolla
  • , Xiao Ou Shu
  • , Yingchang Lu
  • , Qiuyin Cai
  • , Fares Al-Ejeh
  • , Esdy Rozali
  • , Qin Wang
  • , Joe Dennis
  • , Bingshan Li
  • , Chenjie Zeng
  • , Helian Feng
  • , Alexander Gusev
  • , Richard T. Barfield
  • , Irene L. Andrulis
  • Hoda Anton-Culver, Volker Arndt, Kristan J. Aronson, Paul L. Auer, Myrto Barrdahl, Caroline Baynes, Matthias W. Beckmann, Javier Benitez, Marina Bermisheva, Carl Blomqvist, Natalia V. Bogdanova, Stig E. Bojesen, Hiltrud Brauch, Hermann Brenner, Louise Brinton, Per Broberg, Sara Y. Brucker, Barbara Burwinkel, Trinidad Caldés, Federico Canzian, Brian D. Carter, J. Esteban Castelao, Jenny Chang-Claude, Xiaoqing Chen, Ting Yuan David Cheng, Hans Christiansen, Christine L. Clarke, Margriet Collée, Sten Cornelissen, Fergus J. Couch, David Cox, Angela Cox, Simon S. Cross, Julie M. Cunningham, Kamila Czene, Mary B. Daly, Peter Devilee, Kimberly F. Doheny, Thilo Dörk, Isabel Dos-Santos-Silva, Martine Dumont, Miriam Dwek, Diana M. Eccles, Ursula Eilber, A. Heather Eliassen, Christoph Engel, Mikael Eriksson, Laura Fachal, Peter A. Fasching, Jonine Figueroa, Dieter Flesch-Janys, Olivia Fletcher, Henrik Flyger, Lin Fritschi, Marike Gabrielson, Manuela Gago-Dominguez, Susan M. Gapstur, Montserrat García-Closas, Mia M. Gaudet, Maya Ghoussaini, Graham G. Giles, Mark S. Goldberg, David E. Goldgar, Anna González-Neira, Pascal Guénel, Eric Hahnen, Christopher A. Haiman, Niclas Håkansson, Per Hall, Emily Hallberg, Ute Hamann, Patricia Harrington, Alexander Hein, Belynda Hicks, Peter Hillemanns, Antoinette Hollestelle, Robert N. Hoover, John L. Hopper, Guanmengqian Huang, Keith Humphreys, David J. Hunter, Anna Jakubowska, Wolfgang Janni, Esther M. John, Nichola Johnson, Kristine Jones, Michael E. Jones, Audrey Jung, Rudolf Kaaks, Michael J. Kerin, Elza Khusnutdinova, Veli Matti Kosma, Vessela N. Kristensen, Diether Lambrechts, Loic Le Marchand, Jingmei Li, Sara Lindström, Jolanta Lissowska, Wing Yee Lo, Sibylle Loibl, Jan Lubinski, Craig Luccarini, Michael P. Lux, Robert J. MacInnis, Tom Maishman, Ivana Maleva Kostovska, Arto Mannermaa, Jo Ann E. Manson, Sara Margolin, Dimitrios Mavroudis, Hanne Meijers-Heijboer, Alfons Meindl, Usha Menon, Jeffery Meyer, Anna Marie Mulligan, Susan L. Neuhausen, Heli Nevanlinna, Patrick Neven, Sune F. Nielsen, Børge G. Nordestgaard, Olufunmilayo I. Olopade, Janet E. Olson, Håkan Olsson, Paolo Peterlongo, Julian Peto, Dijana Plaseska-Karanfilska, Ross Prentice, Nadege Presneau, Katri Pylkäs, Brigitte Rack, Paolo Radice, Nazneen Rahman, Gad Rennert, Hedy S. Rennert, Valerie Rhenius, Atocha Romero, Jane Romm, Anja Rudolph, Emmanouil Saloustros, Dale P. Sandler, Elinor J. Sawyer, Marjanka K. Schmidt, Rita K. Schmutzler, Andreas Schneeweiss, Rodney J. Scott, Christopher G. Scott, Sheila Seal, Mitul Shah, Martha J. Shrubsole, Ann Smeets, Melissa C. Southey, John J. Spinelli, Jennifer Stone, Harald Surowy, Anthony J. Swerdlow, Rulla M. Tamimi, William Tapper, Jack A. Taylor, Mary Beth Terry, Daniel C. Tessier, Abigail Thomas, Kathrin Thöne, Rob A.E.M. Tollenaar, Diana Torres, Thérèse Truong, Michael Untch, Celine Vachon, David Van Den Berg, Daniel Vincent, Quinten Waisfisz, Clarice R. Weinberg, Camilla Wendt, Alice S. Whittemore, Hans Wildiers, Walter C. Willett, Robert Winqvist, Alicja Wolk, Lucy Xia, Xiaohong R. Yang, Argyrios Ziogas, Elad Ziv, Alison M. Dunning, Paul D.P. Pharoah, Jacques Simard, Roger L. Milne, Stacey L. Edwards, Peter Kraft, Douglas F. Easton, Georgia Chenevix-Trench*, Wei Zheng
*Corresponding author for this work
  • Vanderbilt University
  • Queensland Institute of Medical Research
  • University of Cambridge
  • Cyprus Institute of Neurology and Genetics
  • Harvard University
  • Dana-Farber Cancer Institute
  • Brigham and Women’s Hospital
  • University of Toronto
  • University of California at Irvine
  • German Cancer Research Center
  • Queen's University Kingston
  • Fred Hutchinson Cancer Research Center
  • University of Wisconsin-Milwaukee
  • Friedrich-Alexander University Erlangen-Nürnberg
  • Spanish National Cancer Research Centre
  • Centro de Investigación en Red de Enfermedades Raras (CIBERER)
  • Russian Academy of Sciences
  • Hannover Medical School
  • Helsinki University Hospital
  • Örebro University
  • N.N. Alexandrov Research Institute of Oncology and Medical Radiology
  • University of Copenhagen
  • Robert Bosch Foundation
  • University of Tübingen
  • National Institutes of Health
  • Lund University
  • Heidelberg University 
  • Hospital Clínico San Carlos de Madrid
  • American Cancer Society
  • Xerencia de Xestion Integrada de Vigo-SERGAS
  • University of Hamburg
  • University of Florida
  • University of Sydney
  • Erasmus University Rotterdam
  • Antoni van Leeuwenhoek Hospital
  • Mayo Clinic Rochester, MN
  • Imperial College London
  • INSERM U1052
  • University of Sheffield
  • Karolinska Institutet
  • Fox Chase Cancer Center
  • Leiden University
  • Johns Hopkins University
  • London School of Hygiene and Tropical Medicine
  • Hôpital du Saint-Sacrement
  • University of Westminster
  • University of Southampton
  • Leipzig University
  • University of California at Los Angeles
  • University of Edinburgh
  • Institute of Cancer Research
  • Curtin University
  • Instituto de Investigación Sanitaria de Santiago de Compostela
  • University of California at San Diego
  • Cancer Council Victoria
  • Centre for Epidemiology and Biostatistics
  • McGill University
  • University of Utah
  • Renal and Cardiovascular Epidemiology
  • University of Cologne
  • University of Southern California
  • Stockholm County Council
  • Leidos Inc
  • Erasmus MC Cancer Institute
  • University of Oxford
  • Pomeranian Medical University in Szczecin
  • Ulm University
  • Cancer Prevention Institute of California
  • Stanford University
  • University of Galway
  • Ufa University of Science and Technology
  • University of Eastern Finland
  • University of Oslo
  • KU Leuven
  • University of Hawai'i at Mānoa
  • Agency for Science, Technology and Research, Singapore
  • University of Washington
  • Maria Sklodowska-Curie Institute of Oncology
  • German Breast Group, GmbH
  • Macedonian Academy of Sciences and Arts
  • Heraklion University Hospital
  • VU University Medical Center
  • Technical University of Munich
  • University College London
  • University Health Network
  • City of Hope National Med Center
  • The University of Chicago
  • FIRC Institute of Molecular Oncology
  • University of Oulu
  • Northern Finland Laboratory Centre Oulu
  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
  • Carmel Medical Center
  • Hospital Universitario Puerta de Hierro Majadahonda
  • Guy's and St Thomas' NHS Foundation Trust
  • Hunter New England Health
  • University of Newcastle
  • University of Melbourne
  • Provincial Health Services Authority
  • University of British Columbia
  • Columbia University
  • Universidad Javeriana
  • Helios Clinics Berlin-Buch
  • University of California at San Francisco

Research output: Contribution to journalArticlepeer-review

Abstract

The breast cancer risk variants identified in genome-wide association studies explain only a small fraction of the familial relative risk, and the genes responsible for these associations remain largely unknown. To identify novel risk loci and likely causal genes, we performed a transcriptome-wide association study evaluating associations of genetically predicted gene expression with breast cancer risk in 122,977 cases and 105,974 controls of European ancestry. We used data from the Genotype-Tissue Expression Project to establish genetic models to predict gene expression in breast tissue and evaluated model performance using data from The Cancer Genome Atlas. Of the 8,597 genes evaluated, significant associations were identified for 48 at a Bonferroni-corrected threshold of P < 5.82 × 10 -6 , including 14 genes at loci not yet reported for breast cancer. We silenced 13 genes and showed an effect for 11 on cell proliferation and/or colony-forming efficiency. Our study provides new insights into breast cancer genetics and biology.

Original languageEnglish
Pages (from-to)968-978
Number of pages11
JournalNature Genetics
Volume50
Issue number7
DOIs
Publication statusPublished - 1 Jul 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer'. Together they form a unique fingerprint.

Cite this